Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by peopleofpathology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by peopleofpathology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network

35:56
 
Share
 

Manage episode 500944608 series 3385006
Content provided by peopleofpathology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by peopleofpathology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia.

What we discuss with Arun and Tom:

  • Introduction to Proscia’s Diagnostic Network
  • Reshaping the economics of pathology
  • Economic opportunities in digital pathology
  • Data as an asset in biomarker discovery
  • Clinical trials as use cases
  • Compliance and security in digital pathology
  • Pathology's central role in treatment
  • Accelerating digital adoption and ROI
  • Patient benefits and clinical trials
  • Risks and barriers in digital pathology
  • Advice for labs considering digital pathology
  • Market adoption and future vision

Links for this episode:

The Path to PathA

Pathologists' Assistant Shadowing Network

Health Podcast Network

LabVine Learning

Dress A Med scrubs

Digital Pathology Club

Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases

Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center

People of Pathology Podcast:

Twitter

Instagram

  continue reading

213 episodes

Artwork
iconShare
 
Manage episode 500944608 series 3385006
Content provided by peopleofpathology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by peopleofpathology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia.

What we discuss with Arun and Tom:

  • Introduction to Proscia’s Diagnostic Network
  • Reshaping the economics of pathology
  • Economic opportunities in digital pathology
  • Data as an asset in biomarker discovery
  • Clinical trials as use cases
  • Compliance and security in digital pathology
  • Pathology's central role in treatment
  • Accelerating digital adoption and ROI
  • Patient benefits and clinical trials
  • Risks and barriers in digital pathology
  • Advice for labs considering digital pathology
  • Market adoption and future vision

Links for this episode:

The Path to PathA

Pathologists' Assistant Shadowing Network

Health Podcast Network

LabVine Learning

Dress A Med scrubs

Digital Pathology Club

Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases

Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center

People of Pathology Podcast:

Twitter

Instagram

  continue reading

213 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play